Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Equity Average (2020 - 2025)

RxSight (RXST) has disclosed Equity Average for 6 consecutive years, with $275.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 1.23% year-over-year to $275.8 million, compared with a TTM value of $275.8 million through Dec 2025, down 1.23%, and an annual FY2025 reading of $278.5 million, up 26.11% over the prior year.
  • Equity Average was $275.8 million for Q4 2025 at RxSight, roughly flat from $277.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $280.3 million in Q1 2025 and bottomed at -$366.2 million in Q1 2021.
  • Average Equity Average over 5 years is $123.5 million, with a median of $155.2 million recorded in 2023.
  • Peak annual rise in Equity Average hit 226.73% in 2022, while the deepest fall reached 35.72% in 2022.
  • Year by year, Equity Average stood at $144.6 million in 2021, then tumbled by 35.72% to $92.9 million in 2022, then surged by 73.16% to $160.9 million in 2023, then surged by 73.53% to $279.2 million in 2024, then dropped by 1.23% to $275.8 million in 2025.
  • Business Quant data shows Equity Average for RXST at $275.8 million in Q4 2025, $277.0 million in Q3 2025, and $278.7 million in Q2 2025.